Physician profile
Benjamin Wilson
NPI 1093100083
$2,583.96
in general payments reported to CMS, 2019-2025
18 companies · $983 in 2025
The $983 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.48 · 2020: $142 · 2021: $310 · 2022: $351 · 2023: $327 · 2024: $456 · 2025: $983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,688 · Education: $77.97.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,687.68 |
| Education | $77.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $578.22 | 2023-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals Lp | $468.47 | 2020-2025 | Lynparza |
| Glaxosmithkline, LLC. | $352.02 | 2020-2025 | Jemperli, Zejula |
| Conmed Corporation | $256.89 | 2024-2025 | Airseal, Conmed Specimen Retrieval |
| Seagen INC. | $198.12 | 2022-2023 | Tivdak |
| Merck Sharp & Dohme LLC | $180.70 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Abbvie INC. | $136.73 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $106.93 | 2023-2024 | Myrisk |
| Tempus Ai, INC | $49.93 | 2024-2025 | Xt Cdx |
| Eisai INC. | $45.12 | 2025 | |
| Ethicon US, LLC | $41.51 | 2022-2025 | Enseal |
| Astellas Pharma US INC | $35.85 | 2024 | Veozah |
| Integra Lifesciences Corporation | $31.56 | 2022 | |
| Medtronic, INC. | $31.41 | 2023-2025 | Gia, Signia |
| Boston Scientific Corporation | $22.54 | 2025 | Spyglass Discover |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.03 | 2025 | |
| Novo Nordisk INC | $15.45 | 2022 | |
| Tesaro, INC. | $14.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.